Topics:
Head and Neck Cancers • Radiation Oncology
Per the latest ASCO and ESMO guidelines, which stage II NPC patients would you omit concurrent cisplatin?
Answer from: Radiation Oncologist at Academic Institution
ASCO recommendations for stage II NPC are: “For T2N0 (AJCC 8th) NPC patients, chemotherapy is not routinely recommended, but may be offered if there are adverse features, such as bulky tumor volumes or high EBV DNA copy number. For T1-2N1 NPC patients, concurrent chemotherapy may be offered, p...
Sign in or Register to read more